Effect of Simvastatin to Urine and Bladder Macroscopic Tissue In Protamin Sulfate-Induced Acute Intersititial Cystitis Rat Model
Abstract
The pathophysiology of interstitial cystitis (IC) is complicated and related to statin drug use without any established underlying mechanisms. This study used a rat model of acute IC caused by protamine sulfate to examine the effects of simvastatin on bladder and urine macro-tissue after simvastatin treatment. There were 12 adult female Wistar rats. Simvastatin 10 mg/kgBB + protamine sulfate group (S10P), Simvastatin 50 mg/kgBB + protamine sulfate group (S50P), and Placebo + Protamin Sulfate group (KP) were the three groups (each n=4) into which the subjects were grouped. Simvastatin or placebo CMC 0,5% was administered orally to all animals for 30 days, followed by an intravesical protamine sulfate (10 mg/ml) instillation procedure. All animals were gathered three days after intravesical therapy to collect urine samples and bladder tissue. Simvastatin group participants' levels of hematuria were significantly higher than those of the control group (p = 0.03). Only relative bladder weight was substantially higher in the S50P group than in the control group (p=0.032). Simvastatin group members did not substantially vary from the control group regarding bladder macroscopic oedema and haemorrhage. To conclude, simvastatin may influence the condition of tissue hypervascularization and hypertrophy, contributing to the chronicity of acute interstitial cystitis.
References
Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. The Lancet. 2019 Feb 2;393(10170):407–15.
Harrison TN, Scott RD, Cheetham TC, Chang SC, Hsu JWY, Wei R, et al. Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol. Cardiovasculer Drugs and Therapy, 2018 Aug;32(4):397–404.
Ward NC, Watts GF, Eckel RH. Statin Toxicity. Circ Res. 2019 Jan 18;124(2):328–50.
Bytyçi I, Penson PE, Mikhailidis DP, Wong ND, Hernandez AV, Sahebkar A, et al. Prevalence of statin intolerance: a meta-analysis. European Heart Journal, 2022 Sep 7;43(34):3213–23.
Turner RM, Pirmohamed M. Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components. Journal of Clinical Medicine, 2019 Dec 20;9(1):22.
Liu A, Wu Q, Guo J, Ares I, Rodríguez JL, Martínez-Larrañaga MR, et al. Statins: Adverse reactions, oxidative stress and metabolic interactions. Pharmacology & Therapeutics, 2019 Mar 1;195:54–84.
Huang CY, Chung SD, Kao LT, Lin HC, Wang LH. Statin Use Is Associated with Bladder Pain Syndrome/Interstitial Cystitis: A Population-Based Case-Control Study. Urologia Internationalis, 2015;95(2):227–32.
Eaton AF, Clayton DR, Ruiz WG, Griffiths SE, Rubio ME, Apodaca G. Expansion and contraction of the umbrella cell apical junctional ring in response to bladder filling and voiding. Molecular Biology of Cell, 2019 Jul 22;30(16):2037–52.
Jhang JF, Jiang YH, Kuo HC. Current Understanding of the Pathophysiology and Novel Treatments of Interstitial Cystitis/Bladder Pain Syndrome. Biomedicines, 2022 Oct;10(10):2380.
Wan Q, Xiong G, Liu G, Shupe TD, Wei G, Zhang D, et al. Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction. Stem Cell Research & Therapy, 2018 Nov 8;9:304.
Malik ST, Birch BR, Voegeli D, Fader M, Foria V, Cooper AJ, et al. Distribution of mast cell subtypes in interstitial cystitis: implications for novel diagnostic and therapeutic strategies? Journal of Clinical Pathology, 2018 Sep;71(9):840–4.
Chen YT, Yang CC, Sung PH, Lin KC, Chiang JY, Huang CR, et al. Long-term effect of extracorporeal shock wave therapy on attenuating radiation-induced chronic cystitis in rat. American Journal of Translational Research, 2020;12(3):999–1015.
Yusuf MNS, Hasanuddin ADI, Yusuf ZK, Tuna T, Ibrahim N, Posumah MT, et al. Effect of Simvastatin on Eosinophilic Inflammation of Bladder Tissue in Interstitial Cystitis Rat Model. Jurnal Kedokteran Brawijaya. 2022 Nov 4;76–81.
Di Capua-Sacoto C, Sanchez-Llopis A, Oconnor JE, Martinez-Romero A, Ruiz-Cerdá JL. Apoptotic effect as biomarker of disease, severity and follow-up in interstitial cystitis. Actas Urologicas Espariolas (Engl Ed), 2018 May;42(4):262–6.
Shen JD, Chen SJ, Chen HY, Chiu KY, Chen YH, Chen WC. Review of Animal Models to Study Urinary Bladder Function. Biology. 2021 Dec;10(12):1316.
Birder LA. Pathophysiology of interstitial cystitis. International Journal of Urology, 2019 Jun;26(S1):12–5.
Birder L, Andersson KE. Animal Modelling of Interstitial Cystitis/Bladder Pain Syndrome. Int Neurourology Journal, 2018 Jan;22(Suppl 1):S3-9.
Grundy SM, Vega GL, Wong ND. Is There a Role for Coronary Calcium in Patients With Diabetes?. The American Journal of Cardiology, 2023 Mar 1;190:98–101.
Crespo MJ, Quidgley J. Simvastatin, atorvastatin, and pravastatin equally improve the hemodynamic status of diabetic rats. World Journal of Diabetes, 2015 Aug 25;6(10):1168– 78.
Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension, 2001 Jun;37(6):1450–7.
Peric D, Barragan I, Giraud-Triboult K, Egesipe AL, Meyniel-Schicklin L, Cousin C, et al. Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem Cells. Stem Cells, 2015 Oct 1;33(10):2936–48.
Van Hattum JW, Scutigliani EM, Helderman RFCPA, Zweije R, Rodermond HM, Oei AL, et al. A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer. Scientific Reports, 2022 Apr 29;12(1):7017.
Sahiner IF, Soylu H, Ates E, Acar N, Ustunel I, Danısman A. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model. International braz j urol, 2018 Oct;44(5):1014–22.
Sequeira-Antunes B, Ferreira HA. Urinary Biomarkers and Point-of-Care Urinalysis Devices for Early Diagnosis and Management of Disease: A Review. Biomedicines, 2023 Apr;11(4):1051.
Pires MV, de Lima CJ, Carvalho HC, Moreira LH, Fernandes AB. Effectiveness of intravesical ozone in interstitial cystitis by the O’Leary–Sant symptom index. International Urogynecology Journal, 2023 Jul 1;34(7):1437–46.
Shin JI, Fine DM, Sang Y, Surapaneni A, Dunning SC, Inker LA, et al. Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria. Journal of The American Society of Nephrology, 2022 Sep;33(9):1767–77.
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 2019 Feb;39(2):e38–81.
Jitpratoom P, Boonyasiri A. Determinants of urinary tract infection in hospitalized patients with acute ischemic stroke. BMC Neurology, 2023 Jun 30;23(1):251.
Di Micco R, Krizhanovsky V, Baker D, d’Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nature Reviews Molecular Cell Biology, 2021 Feb;22(2):75–95.
Blagosklonny MV. Cellular senescence: when growth stimulation meets cell cycle arrest. Aging (Albany NY). 2023 Feb 19;15(4):905–13.
Rana T, Jiang C, Liu G, Miyata T, Antony V, Thannickal VJ, et al. PAI-1 Regulation of TGF-β1–induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages. American Journal of Respiratory Cell and Molecular Biology, 2020 Mar;62(3):319–30.
Copyright (c) 2023 Abdi Dzul Ikram Hasanuddin, Rahmawati Minhajat, Mirna Muis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Once an article was published in the journal, the author(s) are: granted to the journal right licensed under Creative Commons License Attribution that allows others to share the work with an acknowledgement of the work's authorship. permitted to publish their work online in third parties as it can lead wider dissemination of the work. continue to be the copyright owner and allow the journal to publish the article with the CC BY-NC-SA license receiving a DOI (Digital Object Identifier) of the work.
